MS
Michael Secora (Chief Financial Officer) filed 1 Form 4 report in the past 24 months (0 purchases, 1 sale), most often in Recursion Pharmaceuticals, Inc. (RXRX). The largest single filing was $230K of RXRX (30,000 sh across 2 lots, as filed), executed Nov 12 2024. Data as of Nov 8 2026.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
1
0 buys · 1 sells
Median delay
–
measured on stock purchases
Volume, ttmiDollar value disclosed in the trailing twelve months
–
no filings in the window
Last traded
Nov 13 2024
Filed Nov 14 2024
Median ADV $67.5M across their filed names
Open performance→Sectors filed on
Healthcare
1 filing
Sector per market data · by filing · past 24 months
Most traded names
RXRXRecent filings
RXRXSALE
Recursion Pharmaceuticals, Inc.
View filing →
$230K30,000 sh across 2 lots
Exec Nov 12 2024
Filed Nov 14 2024 · 5:30 PM ET